Dark

NBIX
Neurocrine Biosciences Inc
stock NASDAQ

Market Open

Jun 9, 2025 11:15:03 AM EDT

124.67USD-0.574%(-0.72)196,642

124.03Bid 124.74Ask 0.71Spread

Pre-market

Jun 4, 2025 8:00:30 AM EDT

125.00USD-0.311%(-0.39)0

After-hours

Jun 6, 2025 4:00:30 PM EDT

125.39USD+0.016%(+0.02)0

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

12.36B

CEO

Kevin Gorman

Headquarters

San Diego, California, USA

Industry

Drug Manufacturers-Specialty & Generic

Next Earnings

Jul 30, 2025 (51d)

RGEN ATHX LLY PFE PTN ABBV ANIP CASI PRTK XLV

NBIX Stats

Avg. Vol. 10 Day

1,090,824

Avg. Vol. 30 Day

1,420,146

Employees

470

Market Cap

12,358,495,325

Shares Out.

98,965,820

On/Off Exchange

56%/44%

6 Month Beta

0.84

1 Year Beta

0.82

2 Year Beta

0.71

3 Year Beta

0.61

52 Week Low

84.23

52 Week High

157.98

SMA50

111.21

SMA200

122.11

1 Week

+0.25%

1 Month

+7.92%

3 Month

+12.63%

6 Month

-3.29%

1 Year

-7.29%

2 Year

+33.72%

5 Year

+5.10%

Profile

neurocrine biosciences, inc of san diego is a product based biopharmaceutical company focusing on the development and commercialization of innovative pharmaceutical products to treat unmet medical needs. the company's research and development efforts are focused on neurological and endocrine diseases and disorders. our product candidates address some of the largest pharmaceutical markets in the world including endometriosis, irritable bowel syndrome, anxiety, depression, pain, diabetes, insomnia, and other neurological and endocrine related diseases and disorders

NBIX Stock Summary

Neurocrine Biosciences Inc (NASDAQ:NBIX) stock price today is $124.67, and today's volume is 196,642. NBIX is down -0.574% today. The 30 day average volume is 1,420,146. NBIX market cap is 12.36B with 98,965,820 shares outstanding.